Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered
Human content, AI powered search.

Latest Stories

Search

Human content, AI powered search.

Search Results for type 2 diabetes

Dr Reddy's launches oral semaglutide biosimilar in India
News

Dr Reddy's launches oral semaglutide biosimilar in India

Oral semaglutide belongs to the Glucagon-Like Peptide-1 (GLP-1) receptor agonist class of drugs used to improve blood sugar control in adults with type 2 diabetes

18-month rebound risk warning for Ozempic, Wegovy
Obesity & Weight Management

Weight loss rebound risk: 18-month warning for Ozempic and Wegovy users

GLP-1 users gain the lost weight within 18 months (four times more) compared with people who go on diet and do exercise

Diabetes drug mimics biological effects of intense exercise Study
News

Diabetes drug mimics biological effects of 'intense' exercise: Study

Anti-diabetic drug Metformin may help prevent age-related macular degeneration: Study
News

Anti-diabetic drug Metformin may help prevent age-related macular degeneration: Study

AMD is an age-related retinal condition causing partial vision loss from the loss of central vision

CPPE launches workshop for Type 2 diabetes management
News

CPPE launches workshop for Type 2 diabetes management

New ‘Optimise’ programme focuses on SGLT2 inhibitors, GLP-1 receptor agonists, and person-centred consultation skills

Stopping weight loss jabs can leave some 'worse off than before': Study
Obesity & Weight Management

Stopping weight loss jabs can  leave some 'worse off than before': Study

Cambridge University researchers found that after stopping the jabs for 52 weeks, people on average regained 60 percent of the weight they lost

NICE allows early use of SGLT-2 inhibitors for diabetes patients to protect heart, kidneys
News

NICE allows early use of SGLT-2 inhibitors for diabetes patients to protect heart, kidneys

NICE analysis found that introducing SGLT-2 medicines earlier in the treatment pathway helps reduce the risk of heart attacks, strokes and kidney problems

MHRA revises semaglutide info over rare eye risk
Drug Safety & Medicine Alerts

MHRA revises semaglutide product information for rare risk of eye disease

Semaglutide helps patients with type 2 diabetes. It is also prescribed for weight management and cardiovascular risk reduction among obese patients